SageOne Smallcap Portfolio PMS Review: Performance, Fees & Should You Stay Invested?
| What Works | What Doesn’t |
|---|---|
| Genuine, disciplined pure-play SmallCap mandate — no style drift into large or mid-caps | 13.75% profit share on all profits, with no hurdle rate — the fee bites from rupee one of gain |
| Positive alpha over the benchmark across 1-year, 2-year, 3-year and since-inception periods | 5-year alpha is essentially flat to negative — the “recent normal” looks very different from the “since-inception story” |
| Long-tenured, founder-led fund manager with no key-person change since the strategy’s 2019 launch | Only 18 stocks with the top 5 sectors making up 70.5% of the portfolio — high concentration risk |
| Genuine differentiation from a typical diversified mutual fund SmallCap portfolio at the stock-selection level | Top holdings and their exact weights are not disclosed — you’re trusting the process more than verifying it |
| Transparent, well-articulated investment philosophy and long public track record of the fund manager | AUM has grown to ₹1,221 crore in a segment where capacity constraints are real, and a large share of the long-term track record sits in one exceptional calendar year |
Verdict: SageOne’s Smallcap Portfolio has genuinely beaten its benchmark over most trailing periods, and the fund manager has stayed disciplined to a clearly stated mandate.
But a fee structure with no hurdle rate, a concentrated portfolio, and a long-term return profile that leans heavily on one standout year mean you owe it to yourself to check whether the net-of-fee, risk-adjusted math still works for you today.
| Detail | Information |
|---|---|
| AMC | SageOne Investment Managers LLP |
| Fund Manager | Samit Vartak, CFA — Founder & CIO |
| Category | PMS – Small Cap |
| Benchmark | S&P BSE 500 TRI |
| Inception Date | 1 April 2019 (Portfolio age: 7 years, 2 months) |
| Minimum Investment | ₹2,00,00,000 |
| AUM | ₹1,221 crore |
| Number of Stocks | 18 |
| Top 5 Sectors | 70.50% of portfolio |
| Composition | ~94% small cap, ~6% cash & equivalent |
SageOne describes its approach as a bottoms-up search for high-growth, sustainable businesses, with an investment objective of backing companies capable of more than 25% CAGR earnings growth over the medium-to-long term, run with strong corporate governance.
That’s an ambitious, specific mandate — and to the fund’s credit, the portfolio composition largely reflects it: this isn’t a SmallCap fund that quietly behaves like a large-cap fund.
Ninety-four percent of the book sits in small caps.
Here is where mandate promise meets data reality, though.
A 25%+ earnings-growth filter is meant to produce outsized, compounding returns.
What you actually got was one extraordinary year (CY23: +34.92%), a mildly negative year (CY22: -2.59%), a recovery this year (CY26 YTD: +12.6%), and a 5-year trailing alpha that is essentially a rounding error versus the benchmark.
The mandate is real. Whether the outcome has been as consistent as the mandate implies is the question this review exists to help you answer.
Trailing Returns Vs Benchmark (as on 30th June 2026)
| Period | SageOne Smallcap Portfolio | S&P BSE 500 TRI | Alpha (+/-) |
|---|---|---|---|
| 1 Year | 2.10% | -2.00% | +4.10% |
| 2 Year | 3.60% | -1.50% | +5.10% |
| 3 Year | 13.10% | 12.50% | +0.60% |
| 5 Year | 12.00% | 12.20% | -0.20% |
| Since Inception | 21.50% | ~14.00% | +7.50% |
| Year | SageOne Smallcap Portfolio |
|---|---|
| CY22 | -2.59% |
| CY23 | +34.92% |
| CY25 | Negative (exact figure not fully legible in disclosed materials) |
| CY26 YTD | +12.6% |
Here is the thing about the alpha column.
Four of five trailing periods are positive — the 1-year and 2-year numbers, in particular, show a real edge over a benchmark that’s actually been negative over those windows.
Said plainly: this fund has protected and grown capital in a period where its own benchmark lost money.
But look at the 5-year number. Flat. Slightly negative, in fact — the one period that spans a full cycle rather than a single standout stretch.
Break the calendar years apart and you can see why: a huge share of the long-term outperformance sits inside one year, CY23.
Take that year out, and the “since inception” story looks meaningfully less extraordinary.
Temporary or structural? Hard to say with certainty from outside.
Concentrated, bottom-up SmallCap portfolios are supposed to be lumpy — that’s the nature of the strategy, not automatically a red flag. Small caps went through a sharp correction into CY25, and the fund’s 1-2-year outperformance shows it navigated that better than the index — a fair point in its favour.
What you can’t yet call is whether the next five years look more like the 3-year number (modest alpha) or the since-inception number (outsized alpha).
You’re being asked to make a forward bet on repeatability.
Gross Alpha > Fee = Value Added | Gross Alpha ≈ Fee = Break-Even | Gross Alpha < Fee = Value Destroyed
Based on the disclosed net returns and the fund’s fee structure, SageOne Smallcap Portfolio sits closer to the break-even zone than the value-destroyed zone over the medium term — the fund has generated genuine gross alpha, but a fee structure with no hurdle consumes a large enough share of that alpha that the net edge over a low-cost passive alternative is considerably thinner than the headline numbers suggest, particularly over the 5-year window.
Here is what “no hurdle” actually means for you: most PMS structures only start charging performance fees once returns cross a minimum threshold, typically 8–10%.
This structure doesn’t. If the portfolio makes 3% in a year, 13.75% of that 3% goes to the fee.
You are paying full performance-fee rates for even modest gains — there is no free pass for merely-average years.
| Scenario | Gross Return Assumed (Estimated) | Corpus After 5 Years | Corpus After 7 Years | |||
| SageOne Smallcap Portfolio (Net, after 13.75% profit share, no hurdle) | 14.0% (category median for actively managed SmallCap PMS) | ~₹88.5 lakh | ~₹111.2 lakh | |||
| Actively Managed Small Cap Mutual Fund (Net, after ~1.0% direct-plan expense ratio) | 13.5% (category median for actively managed small cap mutual funds) | ~₹90.1 lakh | ~₹114.1 lakh | |||
| Passive Index Fund (Net, after 0.15% fee) | 12.5% (category median for broad market index) | ~₹89.5 lakh | ~₹113.0 lakh | |||
Look closely at what that table is actually saying.
The PMS was given a 50-basis-point gross return advantage over the category-average small cap mutual fund in this illustration — a real, generous head start reflecting genuine active management skill.
And the fee structure still erases it.
Over both the 5-year and 7-year mark, on ₹50 lakhs, the PMS’s net corpus trails the small cap mutual fund category average, despite the fund manager having been assumed to do better work on a gross basis.
That isn’t a case against active management as a category — it’s a reminder that within active management, fee structure alone can decide which vehicle actually compounds better for you.
That’s not a knock on the fund manager’s stock-picking. It’s a structural fact about a 13.75%-of-everything, no-hurdle fee model compounding against you, year after year, regardless of whether the year was brilliant or merely decent.
The category average won. Again.
Here’s the question that matters more than any performance chart: knowing everything you know today, if you were starting fresh with this exact ₹2 crores, would you sign up for this same product?
Not “should I sell because it’s had a rough patch.”
Not “should I hold because I’ve already committed.”
Just — clean sheet, same facts, same fee structure, same concentration profile — would you choose this today?
If your honest answer is yes, that’s a legitimate, well-reasoned position, and nothing in this article should talk you out of it.
Staying invested because you’ve genuinely re-underwritten the decision is not inertia — it’s discipline.
But if you find yourself hesitating, pay attention to that hesitation. It’s usually not really about the fund manager’s skill.
It’s about something quieter — the sunk cost of the exit load you already paid once, the discomfort of admitting a decision needs revisiting, the simple momentum of a SIP or standing instruction nobody’s stopped to reconsider.
Would you sign this same contract today, knowing what you now know about the no-hurdle fee, the concentration in five sectors, and the fact that the long-term story leans heavily on one exceptional year?
Staying invested is not the “safe default” choice that requires no justification.
It is a choice — and in a portfolio this size, it deserves the same scrutiny you’d apply to a fresh ₹2 crore decision.
| Decision Factor | Rating | Analysis |
|---|---|---|
| Uniqueness vs existing MF portfolio | 🟡 Mixed | A concentrated, 18-stock portfolio is structurally harder for a diversified mutual fund to replicate — a genuine point in its favour. But check this yourself: Platform Business, Capital Goods, Finance, Managed Spaces, and Specialty Chemicals (70.5% of the book) are popular, well-covered themes your existing SmallCap and multi-cap funds may already be overweight. Undisclosed stock weights mean you can verify sector overlap, not full stock overlap. |
| Alpha consistency across all periods | 🟢 Pass | Four of five disclosed trailing periods show positive alpha, including a strong 1-year and 2-year showing against a negative benchmark — real outperformance through a hard market. The soft spot is the 5-year number, essentially flat. |
| Justification for PMS premium fee | 🟡 Mixed | Gross alpha has clearly existed, but a 13.75% profit share with no hurdle takes an unconditional bite out of every year of gains, good or modest. The rupee-impact illustration above shows this can erase a meaningful gross-return advantage over a passive alternative. The fee is justified only if forward alpha keeps running well ahead of category median. |
| Downside protection in market corrections | 🟡 Mixed | CY22 saw a modest decline (-2.59%), in line with a hard year for small caps broadly. Recent 1-2-year outperformance versus a negative benchmark suggests some resilience. But a 94% SmallCap, 18-stock book is a higher-beta instrument by design — don’t expect it to behave defensively in a sharper drawdown. |
| Portfolio complement for MF investor | 🟢 Pass | Genuinely difficult territory for most mutual funds to access with this concentration and conviction. If you’ve confirmed limited overlap with existing holdings, this is one of the more legitimate cases for a PMS allocation. |
| Mandate purity and discipline | 🟢 Pass | No style drift. The fund has held roughly 94% small cap, consistent with its stated mandate, rather than quietly migrating up the market-cap ladder when small caps struggled. |
| Fund manager transparency | 🟢 Pass | Samit Vartak has a public track record since 1999, is a known voice through newsletters, industry forums, and media, and founded the firm in 2012 with a clearly articulated philosophy — genuinely accessible, not opaque. |
| Investment horizon suitability | 🟡 Mixed | The strategy targets a medium-to-long horizon, and since-inception numbers reward patience. But the 5-year number — arguably the cleanest read on “medium-to-long term” — hasn’t clearly delivered on that promise yet. |
| Market cap flexibility utilisation | 🟢 Pass | A deliberately pure-play SmallCap mandate, not a flexible multi-cap one — the portfolio confirms the manager is executing exactly that, not drifting for comfort. |
| Concentration vs diversification balance | 🔴 Concern | Eighteen stocks with the top five sectors at 70.5% is a genuinely concentrated book. Concentration can add alpha when stock selection works, but it equally amplifies the downside when a theme turns — and the investor bears that fully. |
| AUM size and strategy capacity | 🟡 Mixed | ₹1,221 crores is a substantial AUM for a SmallCap strategy, a segment with real liquidity and market-impact constraints. AUM has grown meaningfully since the standout CY23 year — worth watching as capacity risk tends to show up gradually. |
| Manager tenure and continuity risk | 🟢 Pass | Samit Vartak has run this strategy since its April 2019 inception and led the firm since 2012. No recent manager change, no visible key-person risk. |
| Factor | Rating |
|---|---|
| Uniqueness vs existing MF portfolio | 🟡 |
| Alpha consistency across all periods | 🟢 |
| Justification for PMS premium fee | 🟡 |
| Downside protection in corrections | 🟡 |
| Portfolio complement for MF investor | 🟢 |
| Mandate purity and discipline | 🟢 |
| Fund manager transparency | 🟢 |
| Investment horizon suitability | 🟡 |
| Market cap flexibility utilisation | 🟢 |
| Concentration vs diversification balance | 🔴 |
| AUM size and strategy capacity | 🟡 |
| Manager tenure and continuity risk | 🟢 |
We build client portfolios around a simple, unfashionable idea: your core should be low-cost, diversified, and boringly reliable — index funds, flexi-cap funds, multi-asset allocation.
Your satellite should earn its place by doing something your core structurally cannot do — reaching genuinely differentiated opportunities, not duplicating what you already own at a steeper price.
That distinction matters here specifically. A pure, concentrated, 94%-SmallCap, 18-stock PMS can be a legitimate satellite allocation — this isn’t a large-cap-masquerading-as-active-management situation, where the fee genuinely can’t be justified because an index fund does the same job for a fraction of the cost.
This strategy is doing something structurally different from a plain index fund.
The open question isn’t whether the strategy is differentiated. It’s whether, after a no-hurdle 13.75% fee, the differentiation still pays for itself in your hands.
Regardless of which specific strategy you’re evaluating, a satellite PMS allocation should generally satisfy a few tests:
If you’re evaluating whether to exit, the mechanics matter as much as the decision itself.
Exit load: 3.00% in Year 1, 2.00% in Year 2, 1.00% in Year 3, and nil thereafter. If you’re inside your first three years, this cost needs to be weighed against the ongoing fee drag of staying invested — it’s a one-time cost versus a recurring one.
Tax treatment: PMS structures hold securities directly in your own demat account, which means capital gains are computed at the stock level, not at the fund level like a mutual fund. Long-term capital gains (holding period over 12 months for listed equity) and short-term capital gains are calculated on each individual stock sold, which gives you more control over the timing of realisation — you can choose to stagger exits across tax years if that suits your situation.
Staggered exit strategy: If you decide to exit, consider doing it in tranches rather than all at once, particularly if you’re still inside the exit-load window on part of your investment, or if realising the full gain in a single tax year pushes you into a less favourable bracket.
Timing note: There is no universally “right” time to exit a concentrated equity strategy — trying to time it around a recent good or bad quarter usually adds noise, not value. The zero-based question above is a better guide than market timing.
Q1. Is SageOne Smallcap Portfolio a good PMS?
It has delivered genuine alpha over most trailing periods and stayed disciplined to its mandate. Whether it’s “good” for you depends on your fee sensitivity, portfolio overlap, and comfort with concentration risk.
Q2. What is SageOne PMS’s minimum investment?
₹2,00,00,000 (₹2 crore) for the Smallcap Portfolio.
Q3. What is SageOne’s PMS AUM?
Approximately ₹1,221 crores as on 30 June 2026 for this strategy.
Q4. What are SageOne PMS fees?
No fixed fee option in SageOne PMS. Variable fee: 13.75% profit sharing on all profits, no hurdle rate. Exit load: 3%/2%/1% over the first three years.
Q5. How has SageOne Smallcap Portfolio performed against its benchmark?
SageOne Smallcap Portfolio PMS has outperformed the S&P BSE 500 TRI over 1-year, 2-year, 3-year and since-inception periods, and is roughly flat over 5 years.
Q6. Is a PMS better than a mutual fund?
Neither is categorically better — it depends on fee structure, differentiation, and your existing portfolio.
Q7. Should I exit a PMS that’s underperforming?
It depends on whether the underperformance is temporary (style-cycle-driven) or structural (fee or capacity-driven). The zero-based thinking test is a more reliable guide than reacting to one bad quarter.
Q8. How is PMS taxed compared to mutual funds?
PMS holdings sit in your own Demat account and are taxed stock-by-stock, unlike mutual funds, where gains are computed at the fund-unit level.
Q9. What does “no hurdle rate” mean in a PMS fee structure?
The performance fee is charged from the first rupee of profit, rather than only after returns cross a minimum threshold (commonly 8-10% in hurdle-based structures).
Q10. What is a satellite portfolio in the core-satellite strategy?
The smaller, specialised portion of a portfolio — often PMS or AIF — designed to access what a low-cost, diversified core structurally cannot, rather than duplicating it at a higher price.
We don’t recommend this particular PMS. As process-driven investment advisors, our starting point is always your existing portfolio, not a product — we look at what you already hold across mutual funds and PMS, identify genuine overlap and gaps, and help you assess whether a given allocation is complementing your portfolio or simply duplicating it.
If you’d like a CFP-led review of how your current PMS and mutual fund holdings fit together, a complimentary portfolio review is a good place to start.
Listen to this article "How much money do I need to retire?" It's one of…
Listen to this article Ask someone why they invest, and the answer is almost always…
Listen to this article You didn't sign up for a Nifty-tracking portfolio at 2.5% a…
Listen to this article Maybe since the early days, when the numbers looked spectacular. Maybe…
Listen to this article Is investing ₹10,000 every month enough to create meaningful wealth? It's…
Listen to this article Is accumulating ₹5 crores for retirement an impossible dream? Not really.…